tiprankstipranks
Acer Therapeutics regains compliance with Nasdaq listing rules
The Fly

Acer Therapeutics regains compliance with Nasdaq listing rules

Acer Therapeutics announced that The Nasdaq Stock Market LLC has formally notified Acer that the company has regained compliance with the $35M market value of listed securities requirement, and otherwise satisfies all other criteria necessary, for continued listing on The Nasdaq Capital Market. Accordingly, the listing matter is now closed and the previously-scheduled hearing before the Nasdaq Hearings Panel has been cancelled.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on ACER:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles